Charles B. O'Keeffe, Director at CATALYST PHARMACEUTICALS, INC. (CPRX), sold 87,985 shares at $16.04 ($1.4M) on 2022-11-15, disclosed to the SEC on 2022-11-17.
Seasonal sale ($1.4M) by Director — this insider has traded CPRX in November in at least three consecutive prior years. Pattern-driven, low signal.
Negative factors outweigh the positive ones.
| Filing → |
| CPRX | BUY | 2018-12-14 | $50K | — | Filing → |
| CPRX | BUY | 2018-06-08 | $3K | — | Filing → |
| CPRX | BUY | 2018-06-07 | $13K | — | Filing → |